Erythromycin Lactobionate 1g Powder for Solution for Infusion – Summary of Product Characteristics (SmPC) by ADVANZ Pharma. Erythromycin Lactobionate I.V. is a sterile presentation of erythromycin. It is not When administering the product by intermittent infusion do not use solution strengths greater than . includes any possible side effects not listed in this leaflet. Intravenous infusion of mg of erythromycin lactobionate at a constant rate physiologically concentrated or in situations where high dosage of drug can be.

Author: Taudal Dakus
Country: Sweden
Language: English (Spanish)
Genre: Art
Published (Last): 27 March 2006
Pages: 158
PDF File Size: 15.43 Mb
ePub File Size: 10.15 Mb
ISBN: 460-1-94721-712-8
Downloads: 27953
Price: Free* [*Free Regsitration Required]
Uploader: Kall

Known hypersensitivity to erythromycin. Lower Respiratory Tract infections: Tell your doctor or get medical help right away if you have any of the following signs or symptoms that may be related to a very bad side effect:.

However, many people have no side effects or only have minor side effects. Skin and soft tissue infections: Medically reviewed on Sep 5, No special dosage recommendations. For Intermittent Infusion of 1 gram dose: Granules lactobionatte, ErycFollowing intravenous infusion, eythromycin is widely distributed throughout body tissues, including lung tissues.

Post-marketing reports indicate that co-administration of erythromycin with ergotamine or dihydroergotamine has been associated with acute ergot toxicity characterised by vasospasm and ischaemia of the central nervous system, extremities and other tissues see section 4. Subscribe to receive email notifications whenever new articles are published. The infusion should be completed within 8 hours of preparation to ensure potency. The following have been reported: This medicine must be administered by continuous or intermittent intravenous infusion only.


Patients receiving erythromycin concurrently with drugs which can cause prolongation of the QT interval should be carefully monitored. Chest pain, fever, malaise. Similar effects have been observed with concomitant administration of pimozide and clarithromycin, another macrolide antibiotic.

Erythromycin Lactobionate 1g Powder for Solution for Infusion

As a result of this plasma pakage of active steroid may decrease. Erythromycin has been reported to cross the placental barrier in humans, but foetal plasma levels are generally low.

Erythromycin use in patients who are receiving high doses of theophylline may be associated with an increase in serum theophylline levels and potential theophylline toxicity.

Mycoplasma – Mycoplasma pneumoniae, Ureaplasma urealyticum. There have been reports that maternal macrolide antibiotics exposure within 7 weeks of delivery may be associated with a higher insery of infantile hypertrophic pyloric stenosis IHPS. The majority of strains of Haemophilus influenzae are susceptible to the concentrations reached after ordinary doses. To bookmark a medicine you must sign up and log in. Gram positive bacteria – Listeria monocytogenes, Corynebacterium diphtheriae as an adjunct to antitoxinStaphylococci spp, Streptococci spp including Enterococci.


Erythromycin Lactobionate – I.V. Information –

You must check to make sure that it is safe for you to take Erythromycin Lactobionate – I. QTc interval prolongation, torsades de pointes, palpitations, and cardiac rhythm disorders including ventricular tachyarrhythmias. Ery-TabEryPedE. For Continuous Infusion of 1 gram dose: Erythromycin is erythromyycin active against most strains of the following organisms both in vitro and in clinical infections:. CDAD must be considered in all patients who present with diarrhoea following antibiotic use.

Erythromycin interferes with the fluorometric determination erythroomycin urinary catecholamines. These are not all of the side effects that may occur. Name of the medicinal product 2. Erythromycin is contraindicated with ergotamine and dihydroergotamine.

Erythromycin is excreted principally by the liver, so caution should be exercised in administering the antibiotic to patients with impaired hepatic function or concomitantly receiving potentially hepatotoxic agents.

Skin eruptions, pruritus, pacjage, exanthema, angioedema, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme.

Bolus injection IV push is an unacceptable route of administration. Ppackage easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records.